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The mammalian telomere-binding protein Rap1 was
recently found to have additional nontelomeric func-
tions, acting as a transcriptional cofactor and a regu-
lator of the NF-kB pathway. Here, we assess the
effect of disrupting mouse Rap1 in vivo and report
on its unanticipated role in metabolic regulation
and body-weight homeostasis. Rap1 inhibition
causes dysregulation in hepatic as well as adipose
function, leading to glucose intolerance, insulin
resistance, liver steatosis, and excess fat accumula-
tion. Furthermore, Rap1 appears to play a pivotal role
in the transcriptional cascade that controls adipo-
cyte differentiation in vitro. Using a separation-of-
function allele, we show that the metabolic function
of Rap1 is independent of its recruitment to TTAGGG
binding elements found at telomeres and at other
interstitial loci. In conclusion, our study underscores
an additional function for the most conserved telo-
mere-binding protein, forging a link between telo-
mere biology and metabolic signaling.
INTRODUCTION
Telomeres are specialized nucleoprotein structures that protect
the ends of eukaryotic chromosomes from the perils of the
DNA double-stranded break repair activities, thereby ensuring
genomic stability and cellular viability. In mammalian cells, telo-
meric DNA is bound by shelterin, a specialized six-subunit
complex composed of three proteins with DNA-binding
affinities (TRF1, TRF2, and POT1), two anchoring proteins
(TIN2 and TPP1), and one additional member (Rap1), which is
a TRF2-interacting partner (de Lange, 2005). Rap1, also known
as TERF2ip, is unique among the different shelterin subunits in
that it is the most conserved telomere binding protein from
yeast to humans (Li et al., 2000). The evolutionary conservationCof Rap1 is mostly at the level of domain architecture, featuring
an N-terminal BRCT domain that is followed by one (mammals)
or two (budding yeast) central Myb DNA-binding motifs and
a highly conserved protein-protein interaction domain (RCT)
at the C terminus (Li et al., 2000). As a result of these multiple
protein-protein and protein-DNA interaction modules, Rap1
can act as an adaptor protein, participating in different
complexes with various functions (Shore, 1994; Kabir et al.,
2010). Accordingly, the function of Rap1 in different organisms
is highly diverse and not merely constrained to telomeric
chromatin.
Rap1 was first identified in Saccharomyces cerevisiae as a
transcriptional regulator that binds to the upstream activation
site of the MAT alpha locus and ribosomal protein genes (Shore
and Nasmyth, 1987; Kurtz and Shore, 1991). Depending on the
context of its DNA binding, it can act either as a transcriptional
activator or repressor. Later studies found it to be the primary
double-stranded telomere binding protein involved in telomere
length regulation (Lustig et al., 1990; Hardy et al., 1992) and
transcriptional silencing of subtelomeric genes (Kyrion et al.,
1993). Its key function in budding yeast is to protect chromo-
some ends from end-end fusion by inhibiting the nonhomolo-
gous end-joining (NHEJ) repair pathway at telomeres (Pardo
and Marcand, 2005). In Schizosaccharomyces pombe, Rap1
performs similar functions but lacks DNA binding activity,
thereby relying on its interaction with the telomere-associated
protein Taz1 to localize to chromosome ends (Kanoh and Ishi-
kawa, 2001).
Recent in vitro studies have suggested that mammalian Rap1
can bind to DNA directly in a sequence-independent manner
(Arat andGriffith, 2012). However, in vivo analyses in both human
and mouse cells have demonstrated that Rap1 relies completely
on its interaction with TRF2 in order to bind TTAGGG-bearing
telomere repeats. Furthermore, the TRF2-Rap1 association is
crucial for the stability of endogenous Rap1 protein; as evi-
denced in the absence of TRF2, where Rap1 levels in the nucleus
are greatly diminished (Li et al., 2000; Celli and de Lange, 2005).
The chromosome end-protective function of mammalian
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whereby Rap1 was shown to be dispensable for the suppression
of DNA damage signaling, as well as DNA double-stranded
break repair by NHEJ (Martinez et al., 2010; Sfeir et al., 2010).
Instead, in the absence of Ku70/80, Rap1 inhibition was found
to unleash homology-directed repair (HDR) at telomeres (Sfeir
et al., 2010).
The extratelomeric functions of mammalian Rap1 were only
recently revealed by two key discoveries. The first was by Marti-
nez et al., who identified Rap1 as a transcriptional repressor/
activator and detected several metabolic, cancer-related, and
imprinting genes that were deregulated upon deleting Rap1
from mouse embryonic fibroblasts (MEFs). Furthermore, chro-
matin immunoprecipitation sequencing (ChIP-seq) analysis
identified the binding of Rap1 to numerous extratelomeric sites,
including regions that are proximal to Rap1-regulated genes
(Martinez et al., 2010). Rap1 often associates with nontelomeric
sites containing a (TTAGGG)2 consensusmotif that is recognized
by its interacting partner, TRF2. A second, nontelomeric function
for Rap1was revealed in the cytoplasm, where it acts as amodu-
lator of the NF-kB signaling pathway by partnering with IKB
kinase (IKK) to degrade p65, an inhibitor of NF-kB (Teo et al.,
2010).
To test the role of Rap1 in vivo, we have analyzed the pheno-
types associated with Rap1 loss. Here, we report on an unantic-
ipated function of Rap1 in controlling body weight and regulating
metabolism. Rap1 knockout mice display a phenotype charac-
terized by obesity, glucose intolerance, insulin resistance, liver
steatosis, and adipose tissue hypertrophy. Dysregulated hepatic
function and adipose tissue expansion were preceded by signif-
icant alterations in gene expression. Lastly, using a Rap1 mutant
that is incapable of binding TRF2, we show that the effect of
Rap1 on transcriptional control is independent of its recruitment
to TTAGGG-bearing sequences.
RESULTS
Mature-Onset Obesity in Mice Lacking Rap1
Inactivation of Rap1 in vivo was achieved by breeding mice car-
rying a Rap1 floxed allele with EIIa-Cre transgenic mice to
generate a Rap1 knockout allele (Sfeir et al., 2010). We assessed
the biological function of Rap1 by analyzing offspring from
intercrosses of heterozygote mice. Since Rap1+/+ and Rap1/+
mice displayed no significant difference in phenotype, we pooled
their cohorts and compared wild-type (WT) controls (Rap1+/+Figure 1. Obese Phenotypes in Rap1-Deficient Mice
(A) Rap1-KO mice display morphological signs of obesity when compared to Rap
(left) and male (right) mice.
(B) Body-weight curves of Rap1-WT (white boxes) and Rap-KO (black circles) mic
once every 2 weeks. Data represent mean value, and p values were calculated w
(C) Plasma glucose levels during glucose tolerance test (GTT) performed on 6- to
open boxes represent WT control mice (n = 5). Values were normalized to t = 0
Student’s t test (*p < 0.05).
(D) Plasma glucose levels during Insulin tolerance test (ITT) performed on 6-8 wee
t test and (*) indicates p < 0.05.
(E) GTT performed on 24-32 week-old females (right panel) and males (left panel)
males) and open boxes represent WT control mice (n = 18 for females and n = 20
Student’s t test (*p < 0.05).
Cand Rap1/+, referred to as Rap1-WT) to littermate knockout
mice (Rap1/, referred to Rap1-KO). The loss of Rap1 was
confirmed by genotyping PCR (Figure S1A) and western blot
analysis (Figure S1B). As we previously reported, mice lacking
Rap1were alive and fertile (Sfeir et al., 2010). Rap1 null mice sus-
tained no telomere dysfunction (Figure S2) and displayed no
signs of accelerated aging within the first year of life (data not
shown). Surprisingly, Rap1-KO mice displayed a gradual in-
crease in body weight, leading to adult-onset obesity (Figure 1A).
To establish a chronology of overweight occurrence in the
absence of Rap1, we performed regular weight recordings of in-
dividual mice under a standard diet over a 12-month period. By
22 weeks of age, the body weight of Rap1-deficient females
deviated significantly from those of WT littermates (Figure 1B).
However, the difference in body weight among males was less
pronounced; a durable and significant effect was only estab-
lished at 34 weeks of age. Although the underlying basis for
the marked sexual dimorphism of weight gain in mice is un-
known, this phenotype is similar to what has been previously re-
ported for peroxisome proliferator-activated receptor alpha
(PPARa) (Costet et al., 1998) and peroxisome proliferator-acti-
vated receptor gamma coactivator 1 alpha (PGC-1a) (Leone
et al., 2005) knockout mice. By comparing the daily food intake,
we did not observe an increase in food consumption in Rap1-KO
mice when compared to their Rap1-WT counterparts
(Figure S1C), thus implicating altered energy expenditure or
fuel partitioning as possible causes for the excessive weight
gain associated with Rap1 loss. This was supported by careful
metabolic assessment indicating a significant increase in fasting
blood glucose (Figure S1D) as well as plasma insulin and choles-
terol (Figures S1E–S1G) in Rap1-deficient mice as compared
to age-matched Rap1-proficient mice. The glucose tolerance
test (GTT) and insulin tolerance test (ITT) confirmed that Rap1
deficiency led to glucose intolerance and insulin resistance (Fig-
ures 1C–1E). Taken together, these results suggest that Rap1
impairment has adverse metabolic consequences that can
lead to obesity in the mouse.
Rap1 Deficiency Leads to Dysregulated White Adipose
Tissue Function
Obesity is often coupled to excessive expansion of lipid
storing white adipose tissue (WAT), whereas the energy dissi-
pating brown adipose tissue (BAT) inversely correlates with
body mass index (Gesta et al., 2007). Surgical dissection of1-WT controls. Shown are representative photographs of 24-week-old female
e over a period of 56 weeks. Animals were fed a normal chow diet and weighed
ith the Student’s t test (*p < 0.05).
8-week-old female mice. Closed circles represent Rap1-KO mice (n = 5) and
time point. Data represent mean ±SEM. All p values were calculated with the
k-old female mice (n = 5 for each group). p values were calculated by Student’s
mice. Closed circles represent Rap1-KO mice (n = 15 for females and n = 14 for
for males). Data represent mean ±SEM. All p values were calculated with the
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Figure 2. White Adipose Tissue Dysregulation in the Absence of Rap1
(A) Representative photograph of 40-week-old Rap1-KO (left) and Rap1-WT (right) female mice displaying WAT accumulation.
(B) A DEXA scan was performed on 24- to 32-week-old Rap1-WT mice. Fat percentage is represented as average values ±SEM. The Student’s t test was
performed for significance and (*p < 0.05).
(C) Shown are representative sections of intra-abdominal WAT from 6-week-old Rap1-WT and Rap1-KO mice stained with H&E. Morphometric analysis of white
fat cells was carried out using MetaMorph. Cell area was quantified for each genotype and values represent mean ±SEM.
(D) Gene Ontology analysis was performed to classify differentially expressed genes from intra-abdominal WAT of 6-week-old Rap1-KO and Rap1-WT female
mice into biological processes.
(E) Transdifferentiation of MEFs isolated from Rap1-KO and Rap1-WT mice into adipocytes. Lipid accumulation is visualized using oil red O staining.
(F) Shown is a representative image of a transdifferentiated adipocyte stained with oil red O. Lipid accumulation was quantified and normalized to WT levels.
Values are mean ±SEM. A Student’s t test was performed for significance and (*p < 0.05).Rap1-KO mice revealed an excess accumulation of subcutane-
ous as well as intra-abdominal fat (Figures 2A and 3A). To
confirm these observations, we measured body composition
using a dual-energy X-ray absorption (DEXA) scan and noted a
significant increase in the percentage of fat mass in 24- to 32-
week-old Rap1-KO mice relative to age-matched controls (Fig-
ure 2B). Furthermore, morphological analysis of intra-abdominal1850 Cell Reports 3, 1847–1856, June 27, 2013 ª2013 The AuthorsWAT from 6-week-old Rap1-KO mice displayed an increase in
the size of white adipose cells as compared to WAT from age-
matched control mice (Figure 2C). On the other hand, hematox-
ylin and eosin (H&E) staining of interscapular BAT (iBAT) revealed
no difference in themorphology or extent of lipid accumulation in
the iBAT of Rap1-KO mice when compared to WT controls (Fig-
ure S3A). In addition, 6- to 8-week-old Rap1-KO mice were fully
Figure 3. Rap1 Deficiency Alters Liver Metabolism, Leading to Steatosis
(A) Shown is a representative photograph of 24-week-old Rap1-KO and Rap1-WT mice, displaying pale/fatty liver (marked by asterisk) in the absence of Rap1.
(B) Representative H&E (upper) and oil red O (bottom) staining liver sections from 20-week-old WT and Rap1-KO mice. The red stain is an indicator for accu-
mulation of neutral lipids.
(C) Microarray analysis of messenger RNA from the livers of 6-week-old Rap1-KO and Rap1-WT female mice. Heat map representation of differentially expressed
metabolism and inflammation genes. Average gene expression is colored proportionally to signal intensity with blue denoting a lower expression and red
representing high expression.
(D) Gene Ontology analysis and classification of differentially expressed genes into biological processes.
(E) A Venn diagram showing the overlap of Rap1-regulated genes (red) with the PPARa pathway (blue) genes identified usingGSEA analysis (p = 0.00028; Fisher’s
exact test).capable of maintaining body temperature when subjected to
cold challenge (Figure S3B). Furthermore, consistent with the
fact that the thermogenic capacity of mice is unaffected byCRap1, the induction of the Ucp1 gene in iBAT of Rap1-KO
mice exposed to cold temperature (4C) was similar to that of
age-matched control mice (Figure S3C).ell Reports 3, 1847–1856, June 27, 2013 ª2013 The Authors 1851
To further delineate the impact of Rap1 loss on WAT function,
we assessed gene expression patterns of intra-abdominal WAT
using Affymetrix GeneChip microarray. Animals were analyzed
at 6 weeks of age, prior to when the effect of Rap1 deletion on
body weight is evident. Of the total 39,000 transcripts analyzed,
118WAT genes were differentially expressed between Rap1-WT
and Rap1-KO mice (p < 0.05; 93 downregulated and 35 upregu-
lated genes) (Tables S1, S2, and S3). Gene set enrichment anal-
ysis (GSEA) and Gene Ontology (GO) analysis on all differentially
expressed genes indicated a significant deregulation in genes
with a negative impact on metabolism as well as in genes
involved in the developmental process, inflammation, and cell
adhesion (Figure 2D; Tables S1, S2, and S3).
Rap1 Loss Promotes Adipocyte Differentiation of
Immortalized MEFs In Vitro
The discernible hypertrophy of WAT (Figure 2C), together with
the significant deregulation of gene expression (Figure 2D),
prompted us to ask whether Rap1 affects the differentiation of
preadipocytes into WAT. To directly address this question, we
tested the transdifferentiation capacity of fibroblasts into adipo-
cytes using a tissue culture model. SV40-LgT immortalized
MEFs from Rap1 null mice and WT controls were subject to
well-established adipocyte differentiation protocols (Nakae
et al., 2003). Following hormonal induction with insulin, dexa-
methasone, and IBMX, both cell lines displayed morphological
features consistent with adipocyte differentiation. Interestingly,
Rap1-KO MEFs generated significantly more lipid droplets as
indicated by oil red O staining (Figures 2E and 2F). These results
suggest that Rap1 deficiency alters adipogenesis in a cell-auton-
omous manner, leading to increased white fat accumulation.
Rap1 Deficiency Alters Hepatic Metabolism and Leads
to Liver Steatosis
We next turned our attention to the liver due to its central role in
regulating glucose homeostasis, a major pathway that was
significantly impacted in Rap1 null mice (Figures 1C–1E; Fig-
ure S1D). We found that Rap1 deficiency resulted in liver steato-
sis (Figure 3A), a common feature of obesity. This observation
was confirmed by histological analysis that revealed excess fat
droplets accumulation in liver tissue section from Rap1-KO
mice (Figure 3B). Moreover, oil red O staining confirmed the
accumulation of lipid droplets in liver of Rap1 null mice as
compared to their WT counterparts (Figure 3B).
To investigate the biological processes underlying this altered
hepatic phenotype, we assessed the effects of Rap1 inhibition
on gene transcription in the liver of 6-week-old mice. Differential
gene expression analysis revealed 62 genes that were signifi-
cantly deregulated (false discovery rate [FDR] < 0.2) in Rap1
null mice as compared to age-matched controls (Figure 3C; Fig-
ure S4; Tables S4, S5, and S6). The list comprised metabolic
and inflammation-related genes including PGC1-a, very low-
density lipoprotein (Vldlr), and nicotinamide N-methyltransferase
(Nnmt). GO classification of the deregulated genes highlighted
several biological processes that were impacted by the loss of
Rap1, including metabolic and developmental processes as
well as the inflammation gene network (Figure 3D). Furthermore,
GSEA analysis identified a number of pathways that were signif-1852 Cell Reports 3, 1847–1856, June 27, 2013 ª2013 The Authorsicantly deregulated in the context of Rap1 deficiency, the most
notable being the PPAR-a signaling pathway genes (Figure 3E;
Table S6), thereby highlighting a potential connection between
the gene networks of Rap1 and PPAR-a in controlling hepatic
function.
Rap1 Effect on Metabolic Gene Transcription
Is Independent of TRF2-Mediated Recruitment
to TTAGGG Sequence
Previous ChIP-seq analysis revealed that Rap1 occupies thou-
sands of extratelomeric sites, many of which are associated
with genes (Martinez et al., 2010; Yang et al., 2011). Motif discov-
ery tools were utilized to identify ‘‘TTAGGG2’’ as the highest
ranking motif for Rap1 binding to DNA, thereby implicating
TRF2-mediated recruitment of Rap1 to interstitial telomere re-
peats in the regulation of gene transcription. However, 75%
of Rap1-associated genes were devoid of the TTAGGG
consensus motif and the majority were not bound by TRF2 (Mar-
tinez et al., 2010; Yang et al., 2011). Moreover, upon matching
gene expression profiles for Rap1-KO versus Rap1-WT MEF
data sets (Table S7) with the Rap1-binding peaks identified by
ChIP-seq analysis (Martinez et al., 2010), we found that 25% of
the differentially regulated genes were bound by Rap1 (47 of
187; p = 0.0058, Fisher’s exact test), yet only eight genes con-
tained the TTAGGG consensus motif (p = 0.25) (Figure S5; Ta-
bles S7, S8, and S9). This lack of enrichment for the TTAGGG
motif within Rap1-regulated genes prompted us to ask whether
the metabolic function of Rap1 is independent of its TRF2-medi-
ated localization to DNA sequences at telomeres or elsewhere in
the genome. To address this question, we generated an allele of
mouse Rap1 carrying an isoleucine to arginine mutation at amino
acid 312, a conserved residue in the RCT domain that was pre-
viously shown to promote the interaction between human Rap1
and TRF2 (Figure 4A) (Chen et al., 2011). Coimmunoprecipitation
of cotransfected Myc-TRF2 and either WT Flag-Rap1 or Flag-
Rap1 carrying the I312R mutation (referred to as Rap1DTRF2)
in 293T cells confirmed that the I312R mutation blocked the
interaction between the two shelterin subunits (Figure 4B). We
then introducedMyc-Rap1 andMyc-Rap1DTRF2 independently
into Rap1-KO MEFs using stable retroviral transduction. Viral
titers were diluted to ensure that the expression levels of
Rap1-WT and Rap1DTRF2 were similar and comparable to
endogenous levels of Rap1 in control MEFs (Figure S6). Indirect
immunofluorescence indicated thatWTRap1 exhibited a nuclear
punctate pattern that completely colocalized with telomeric
DNA. On the other hand, Rap1DTRF2 failed to localize to telo-
mere repeats, instead displaying a diffused nucleoplasmic label-
ing pattern (Figure 4C). The expression of mutant Rap1 did not
induce a TIF (telomere-dysfunction-induced foci) response (Fig-
ure S6) and did not complement the telomere phenotype associ-
ated with Rap1 deficiency, which is the repression of aberrant
HDR at telomeres (Chen et al., 2011 and data not shown).
Strikingly, Rap1DTRF2 was capable of complementing adipo-
cyte differentiation of Rap1-KOMEFs to similar extent as theWT
allele (Figure 4D). To assess the effect of the Rap1 mutation at
the transcriptional level, we generated and analyzed transcript
profiles of MEFs expressing Rap1DTRF2 and compared them
to gene expression profiles of MEFs expressing either WT
Figure 4. Rap1DTRF2 Complements Transcriptional Defects of Rap1 Null Cells
(A) Schematic of mouse Rap1 protein with its different domains: BRCT, Myb, and RCT. Highlighted in red is the amino acid residue that is important for TRF2
interaction and that was mutated in the Rap1DTRF2 allele.
(B) Coimmunoprecipitation of TRF2 from 293T cells cotransfected with wild-type Rap1 and mutant Rap1DTRF2.
(C) Immunofluorescence showing the localization of WT Rap1 and Rap1DTRF2 allele (detected with MYC antibody in green) in Rap1-deficient MEFs. Telomeres
are detected with a PNA probe in red and DNA is counterstained with DAPI.
(D) Quantification of lipid accumulation in adipocytes derived fromRap1-KOMEFs expressing vector control, WT Rap1, and Rap1DTRF2. Cells were stained with
oil red O 8 days after hormonal induction and levels of lipid were expressed as percentage relative to adipocytes originating from cells expressing Rap1-WT.
Values are mean ±SEM. A Student’s t test was performed for significance (*p < 0.05).
(E) Global transcriptional analysis of Rap1-KO MEFs complemented with vector control, WT Rap1, and Rap1DTRF2. Shown on the left is a row-centered heat
map with hierarchical clustering carried out on the 187 differentially expressed genes. Represented on the right are examples of differentially expressed genes
rescued by the expression of Rap1DTRF2.Rap1 or vector control. Hierarchical clustering with Pearson’s
correlation of the differentially expressed genes revealed that
cells expressing Rap1DTRF2 cosegregate closely with cells ex-Cpressing WT Rap1 but are very distinct from Rap1 null cells (Fig-
ure 4E). A total of 87% of Rap1-deregulated genes were rescued
by Rap1DTRF2, including genes involved in adipogenesis, organell Reports 3, 1847–1856, June 27, 2013 ª2013 The Authors 1853
morphogenesis, and metabolism (Figure 4E; Figure S5; Tables
S7, S8, and S9). In conclusion, our results suggest that transcrip-
tional regulation by Rap1 is independent of its TRF2-mediated
recruitment to TTAGGG-binding elements found at extratelo-
meric sites. Therefore, Rap1most likely relies on alternative tran-
scription factors and/or complexes to control gene expression.
DISCUSSION
Overall, our study sheds light on a yet-unanticipated role for
mammalian Rap1 in normal bodyweight control. Our data estab-
lish that Rap1 acts as a molecular determinant of gene expres-
sion in various metabolic and signaling pathways. Rap1
deficiency leads to a multisystem metabolic derangement
reflected by glucose intolerance, dyslipidemia, liver steatosis,
and excess fat accumulation. Ultimately, this manifests as late-
onset obesity in the Rap1 knockout mice.
Rap1 has been shown to fulfill telomeric as well as nontelo-
meric functions. The latter is consistent with the protein acting
as a regulator of the NF-kB signaling pathway in the cytoplasm
(Teo et al., 2010), in addition to being a general transcriptional
activator/repressor in the nucleus (Martinez et al., 2010). This rai-
ses the question as to what particular Rap1 function is respon-
sible for the metabolic defect we observe herein. The ability of
nontelomeric Rap1DTRF2 to rescue metabolic gene expression
in MEFs to similar extent as WT Rap1 (Figure 4D) provides
sufficient evidence for a telomere-independent role for Rap1 in
metabolism. Furthermore, the obesity phenotypes exhibited in
Rap1-KO mice are most likely not attributed to its role in the
NF-kB pathway, where it was reported that Rap1 activates IKK
and therefore enhances NF-kB signaling (Teo et al., 2010). In
fact, opposite to what would be predicted based on the positive
effect of Rap1 in NF-kB signaling, our microarray data identify a
number of inflammation genes that were significantly upregu-
lated when Rap1 was absent (Figures 2D, 3C, and 3D). Further-
more, IKK and Rap1 knockout mice display completely opposite
phenotypes, with IKK deficiency counteracting obesity induced
by a high-fat diet (Arkan et al., 2005). In conclusion, themetabolic
and obesity defects observed in the Rap1-KO mouse are most
consistent with mammalian Rap1 being a transcriptional regu-
lator controlling a wide range of metabolic genes. This is reminis-
cent of the transcriptional activator/repressor function that has
long been recognized for budding yeast Rap1 in regulating ribo-
somal proteins, glycolytic enzymes, and mating-type factors
(Shore and Nasmyth, 1987; Kurtz and Shore, 1991).
It will be important to determine the mechanism by which
Rap1 regulates transcription. Themajority of genes that were de-
regulated upon Rap1 loss were devoid of the TTAGGG-
consensus motif (Martinez et al., 2010; Yang et al., 2011).
Furthermore, upon introducing into Rap1 null cells a Rap1DTRF2
allele that is unable to bind to the TTAGGG-bearing sequence,
gene expression was largely rescued (Figure 4E). These results
argue against a possible role for the Rap1-TRF2 complex in tran-
scriptional control. Another possibility is that Rap1 binds directly
to DNA, as was recently reported using in vitro approaches (Arat
and Griffith, 2012). We find this scenario to be highly unlikely
given the strong preference of Rap1 for double-stranded/sin-
gle-stranded DNA junctions, uncommonly present in the1854 Cell Reports 3, 1847–1856, June 27, 2013 ª2013 The Authorsgenome. Alternatively, our preferred model is that the effect of
Rap1 on gene expression stems from its ability to act as a
cofactor for a yet-to-be-identified transcriptional complex. This
is in line with recent protein network analyses that highlighted
potential Rap1 interactions with histone proteins and other chro-
matin modifiers (Lee et al., 2011).
Although the mechanism underlying the metabolic phenotype
of Rap1 deficiency remains to be delineated, our observation
draws an interesting link between telomere function and meta-
bolic regulation. One could speculate that mammalian cells
use Rap1 as a general sensor monitoring the stability of chromo-
some ends. Telomere dysfunction was recently shown to
compromise metabolic function in vivo by repressing PGC-
1a-dependent processes (Sahin et al., 2011). Although this effect
might be due to the activation of p53 at deprotected telomeres
(Sahin et al., 2011), it is also possible that Rap1 could be the fac-
tor that relays themessage from the terminal structure to the rest
of the genome. In the latter scenario, significant telomere short-
ening yields insufficient binding sites for shelterin, leading to a
reduction in TRF2 levels (Fujita et al., 2010). In turn, this would
alter the overall levels of Rap1 in the nucleus, ultimately influ-
encing genome-wide transcription. This scenario might explain
the correlation that was recently described between telomere
attrition and diabetes as well as insulin resistance (Gardner
et al., 2005; Murillo-Ortiz et al., 2012; Shen et al., 2012; Salpea
and Humphries, 2010).
Obesity is a major global public health challenge that has now
reached epidemic proportions. Obese individuals are faced with
a markedly increased risk of cardiovascular disease, type 2 dia-
betes, osteoarthritis, and a number of metabolic syndromes. Of
the many genes that have been reported to impact obesity in
mice, only a handful of heritable genes have been identified in
human genetic studies. Whether mutations in Rap1 are associ-
ated with human metabolic syndromes remains to be identified.
Nevertheless, it is intriguing to note that linkage analysis using a
genome-wide association study pertaining to high-adiposity
phenotypes among American Samoans has revealed a sugges-
tive linkage with the locus containing Rap1 (16q23.1) (Aberg
et al., 2009). 16q23.1 was also linked to childhood-obesity phe-
notypes in a French population (Meyre et al., 2004) and was
found in a recent study to be differentially methylated in carriers
of the FTO allele (fat mass and obesity-associated protein)
(Alme´n et al., 2012).
Finally, our study establishes that the loss of a bona fide telo-
meric protein leads to major metabolic derangement, both at the
cellular and organismal level. This underscores how mammalian
cells establish crosstalk between telomere homeostasis and
metabolism, two seemingly unrelated biological processes.EXPERIMENTAL PROCEDURES
All animal studies were conducted in accordancewith the National Institutes of
Health (NIH) guidelines for treatment of animals and were approved by the
Institutional Animal Care and Use Committees at NYU Langone Medical Cen-
ter and at The Rockefeller University. Weight recordings, the DEXA scan, and
the cold-endurance test were done on mice that were fed ad lib. GTT, ITT, and
blood analysis was performed on mice that were fasted overnight. Microarray
analysis was done on 6-week-old mice. RNA was purified from liver, iBAT,
WAT, and cells using TRIzol and RNeasy Mini spin columns. Microarray
hybridization was performed using Affymetrix GeneChip Mouse Genome 430
2.0 arrays. The array data were analyzed using Bioconductor. For further de-
tails, please refer to Extended Experimental Procedures.
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